Article info
Commentary
Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity
- Correspondence to Professor Frank Tacke, Department of Hepatology & Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Berlin, Germany; frank.tacke{at}charite.de
Citation
Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity
Publication history
- Received March 31, 2022
- Accepted April 8, 2022
- First published April 27, 2022.
Online issue publication
May 04, 2023
Article Versions
- Previous version (4 May 2023).
- Previous version (4 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.